OTC Markets OTCPK - Delayed Quote USD

Cardiff Lexington Corporation (CDIX)

Compare
6.50 0.00 (0.00%)
At close: November 20 at 3:00 PM EST
Loading Chart for CDIX
DELL
  • Previous Close 3.08
  • Open 3.08
  • Bid 3.00 x --
  • Ask 6.50 x --
  • Day's Range 3.08 - 3.08
  • 52 Week Range 1.50 - 60.00
  • Volume 6
  • Avg. Volume 10
  • Market Cap (intraday) 97.739M
  • Beta (5Y Monthly) 1.58
  • PE Ratio (TTM) 0.04
  • EPS (TTM) 153.30
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cardiff Lexington Corporation, together with its subsidiaries, operates in health care business in the United States. The company Healthcare, and Real Estate segments. It also provides tax resolution service to individuals and companies that have federal and state tax liabilities; and a range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. In addition, the company engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Las Vegas, Nevada.

www.cardifflexington.com

13

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CDIX

View More

Performance Overview: CDIX

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CDIX
56.67%
S&P 500
24.72%

1-Year Return

CDIX
89.17%
S&P 500
30.82%

3-Year Return

CDIX
91.33%
S&P 500
26.62%

5-Year Return

CDIX
100.00%
S&P 500
91.37%

Compare To: CDIX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CDIX

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    97.74M

  • Enterprise Value

    159.08M

  • Trailing P/E

    0.04

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.64

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    21.14

  • Enterprise Value/EBITDA

    3.85k

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.51%

  • Return on Assets (ttm)

    -0.33%

  • Return on Equity (ttm)

    -27.37%

  • Revenue (ttm)

    7.53M

  • Net Income Avi to Common (ttm)

    -2.71M

  • Diluted EPS (ttm)

    153.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.95M

  • Total Debt/Equity (mrq)

    102.15%

  • Levered Free Cash Flow (ttm)

    -5.07M

Research Analysis: CDIX

View More

Company Insights: CDIX

Research Reports: CDIX

View More

People Also Watch